ORIC PHARMACEUTICALS, INC. Temporary Equity, Liquidation Preference
ORIC PHARMACEUTICALS, INC. (ORIC) had Temporary Equity, Liquidation Preference of $0 as of 2020-12-31, per its 10-K filed 2021-03-23.
Discontinued › Balance Sheet › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2021-03-23
- 2020-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2019-12-31: Temporary Equity, Liquidation Preference $178.06M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-23 |
| 2019-12-31 | $178.06M 10-K · filed 2021-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |